News from Argentum Pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 13, 2017, 21:02 ET Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Trial Against Valeant's JUBLIA®

Today, the U.S. Patent & Trademark Office (PTO) granted Argentum Pharmaceuticals LLC's petition for inter partes review (IPR) against all...


Sep 29, 2017, 14:05 ET Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Trial Against Mylan's DYMISTA®

The U.S. Patent & Trademark Office (PTO) granted a petition for inter partes review (IPR) filed by Argentum Pharmaceuticals LLC and its...


Sep 29, 2017, 13:47 ET Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Trial Against Alcon's TRAVATAN Z®

The U.S. Patent & Trademark Office (PTO) granted a petition for inter partes review (IPR) filed by Argentum Pharmaceuticals LLC and its...


Sep 29, 2017, 13:42 ET Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Trial Against Novartis's AFINITOR®

The U.S. Patent & Trademark Office (PTO) on September 25, 2017 granted Argentum Pharmaceuticals LLC's petition for inter partes review (IPR)...


Aug 11, 2017, 06:59 ET Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Trial Against Novartis' GILENYA®

On August 9, 2017, the U.S. Patent & Trademark Office (PTO) granted Argentum Pharmaceuticals LLC's petition for inter partes review (IPR)...


Apr 18, 2017, 16:01 ET Argentum Pharmaceuticals and Allergan Settle Patent Dispute Over RESTASIS®

Argentum Pharmaceuticals LLC, a generic pharmaceutical company, announced that it has reached a settlement and license agreement with Allergan,...


Mar 23, 2017, 12:09 ET Argentum Persists in Challenging the "Evergreening" Patent on UCB's VIMPAT®

In addition to reaching settlements granting Argentum Pharmaceuticals LLC rights to market lower-cost generics of other patented drugs, Argentum...


Nov 30, 2016, 14:31 ET Argentum and Alcon Settle Patent Dispute Over PAZEO®

Argentum Pharmaceuticals LLC, a generic pharmaceutical company,announced today that it has reached a settlement with Alcon Research, Ltd., related...


Sep 19, 2016, 11:00 ET Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Trial Against Janssen's ZYTIGA®

Today, the U.S. Patent & Trademark Office (PTO) granted Argentum Pharmaceuticals LLC's petition for inter partes review (IPR) against all...


Aug 01, 2016, 18:35 ET Argentum Pharmaceuticals and KVK Tech Succeed in Starting Patent Cancellation Trial Against Alcon's PAZEO®

 The U.S. Patent & Trademark Office (PTO) granted a petition for inter partes review (IPR) filed by Argentum Pharmaceuticals LLC...


May 23, 2016, 19:20 ET Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Trial Against UCB's VIMPAT®

Today, the U.S. Patent & Trademark Office (PTO) granted Argentum Pharmaceuticals LLC's petition for inter partes review (IPR) against all...


Feb 01, 2016, 23:21 ET KVK Tech And Argentum Pharmaceuticals Announce Partnership To Commercialize Pharmaceutical Products Made In The U.S.A.

 Argentum has entered into a nonexclusive collaboration agreement with KVK Tech to launch and commercialize pharmaceutical products.  KVK...